As of 2026-05-20, the Relative Valuation of Legend Biotech Corp (LEGN) is (33.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.94 USD, the upside of Legend Biotech Corp based on Relative Valuation is -223.8%.
The range of the Relative Valuation is (30.61) - (37.30) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 24.5x | 22.9x |
| Forward P/E multiples | 19.8x - 24.1x | 20.2x |
| Fair Price | (30.61) - (37.30) | (33.35) |
| Upside | -213.6% - -238.4% | -223.8% |
| Date | P/E |
| 2026-05-19 | -17.59 |
| 2026-05-18 | -17.43 |
| 2026-05-15 | -17.80 |
| 2026-05-14 | -18.48 |
| 2026-05-13 | -18.53 |
| 2026-05-12 | -18.26 |
| 2026-05-11 | -16.53 |
| 2026-05-08 | -18.17 |
| 2026-05-07 | -18.46 |
| 2026-05-06 | -18.71 |
| 2026-05-05 | -18.42 |
| 2026-05-04 | -17.12 |
| 2026-05-01 | -15.24 |
| 2026-04-30 | -15.20 |
| 2026-04-29 | -14.71 |
| 2026-04-28 | -15.22 |
| 2026-04-27 | -15.28 |
| 2026-04-24 | -15.44 |
| 2026-04-23 | -15.50 |
| 2026-04-22 | -16.76 |
| 2026-04-21 | -16.30 |
| 2026-04-20 | -16.20 |
| 2026-04-17 | -13.68 |
| 2026-04-16 | -13.62 |
| 2026-04-15 | -13.26 |
| 2026-04-14 | -12.08 |
| 2026-04-13 | -11.43 |
| 2026-04-10 | -11.73 |
| 2026-04-09 | -11.76 |
| 2026-04-08 | -11.83 |
| 2026-04-07 | -11.63 |
| 2026-04-06 | -12.07 |
| 2026-04-02 | -12.37 |
| 2026-04-01 | -12.31 |
| 2026-03-31 | -11.69 |
| 2026-03-30 | -11.19 |
| 2026-03-27 | -10.86 |
| 2026-03-26 | -11.30 |
| 2026-03-25 | -11.37 |
| 2026-03-24 | -11.04 |
| 2026-03-23 | -11.13 |
| 2026-03-20 | -11.25 |
| 2026-03-19 | -11.55 |
| 2026-03-18 | -11.77 |
| 2026-03-17 | -11.99 |
| 2026-03-16 | -12.34 |
| 2026-03-13 | -12.12 |
| 2026-03-12 | -12.31 |
| 2026-03-11 | -13.10 |
| 2026-03-10 | -12.64 |